Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…of whether children with gender dysphoria should have access to puberty blockers and masculinising/feminising hormones is a highly politicised i…
… a general practice in Brighton have inappropriately prescribed puberty blockers and hormone treatments to 78 children, an official investigatio…
…A UK clinical trial aiming to assess the effect of puberty blockers on young people with gender incongruence continues to be mired …
…The controversial Pathways trial assessing the effect of puberty blockers on young people with gender incongruence has been paused owing …
…Medical and public concern about a controversial UK trial of puberty blockers is on the rise, as are efforts to derail it.…
…Campaigners against the use of puberty blockers for gender questioning children have taken the first steps towa…
…ial research studies assessing the risks and benefits of giving puberty blockers to young people with gender incongruence will go ahead.1…
…Miroshnychenko A, Roldan Y, Ibrahim S, et al. Puberty blockers for gender dysphoria in youth: A systematic review and meta-ana…
… of the Cass review to limit the provision of puberty blockers (PBs) and cross-sex hormones (CSHs) to a research study. She argues …
…g.1 The indefinite ban on the prescription of puberty blockers (PBs) implemented by NHS England2 in response to the Cass review3 po…
…linical trials have been framed as a precondition for access to puberty blockers for trans youth in England.1 Giordano challenges the ethical co…
…A planned clinical trial to assess the safety of puberty blockers in children with gender distress poses too many ethical and met…